{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1410001204284975489.json","@type":"Researcher","foaf:Person":[{"foaf:name":[{"@language":"en","@value":"FUJIMURA Akio"}]}],"career":[{"institution":{"notation":[{"@language":"en","@value":"Department of Clinical Pharmacology, Jichi Medical School"}]}}],"product":[{"@id":"https://cir.nii.ac.jp/crid/1390001204284975488","@type":"Article","resourceType":"学術雑誌論文(journal article)","productIdentifier":[{"@type":"DOI","@value":"10.1254/jjp.80.209"},{"@type":"COI","@value":"1:CAS:528:DyaK1MXkslKrt7Y%3D"},{"@type":"PMID","@value":"10461765"},{"@type":"NDL_BIB_ID","@value":"4806254"},{"@type":"NDL_CALL_NUMBER","@value":"Z53-D199"},{"@type":"URI","@value":"http://id.ndl.go.jp/bib/4806254"},{"@type":"URI","@value":"https://ndlsearch.ndl.go.jp/books/R000000004-I4806254"},{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0021519819308443?httpAccept=text/xml"},{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0021519819308443?httpAccept=text/plain"},{"@type":"URI","@value":"https://www.jstage.jst.go.jp/article/jjp/80/3/80_3_209/_pdf"},{"@type":"NAID","@value":"10008195191"},{"@type":"URI","@value":"https://search.jamas.or.jp/link/ui/2000025656"}],"notation":[{"@language":"en","@value":"A Comparison of the Antagonistic Activities of Tamsulosin and Terazosin Aganst Human Vascular .ALPHA.1-Adrenoceptors."},{"@value":"A Comparison of the Antagonistic Activities of Tamsulosin and Terazosin Against Human Vascular α1-Adrenoceptors"},{"@language":"ja-Kana","@value":"Comparison of the Antagonistic Activities of Tamsulosin and Terazosin Against Human Vascular アルファ 1 Adrenoceptors"}],"relation":[{"type":"creator"}]}],"dataSourceIdentifier":[{"@type":"JALC","@value":"oai:japanlinkcenter.org:0008649614_aHEw5esZy4blSJ6YwOI8LxvkWsM"},{"@type":"CIA","@value":"10008195191_LZYT7Snf7hfq2RkCRG0Kf9gRKKT"},{"@type":"CROSSREF","@value":"10.1254/jjp.80.209_S02xJ5g4iQh4Lq57mxkAvEpUlR2"},{"@type":"OPENAIRE","@value":"doi_dedup___::02e011b015aab44fc4de53413c2f02b8_S02xJ5g4iQh4Lq57mxkAvEpUlR2"}]}